4
Changes in Ownership
Prime Medicine, Inc. Filed Acc 0001628280-22-027124
Director bought 800,000 shares at $17.00 ($13,600,000)
- Director acquired 11,472,674 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| NELSEN ROBERT Director | 2022-10-24 | Conversion | +5,728,297 | 5,728,297 | I | ||
| NELSEN ROBERT Director | 2022-10-24 | Conversion | +5,728,297 | 5,728,297 | I | ||
| NELSEN ROBERT Director | 2022-10-24 | Purchase | +400,000 | $17.00 | $6,800,000 | 6,128,297 | I |
| NELSEN ROBERT Director | 2022-10-24 | Purchase | +400,000 | $17.00 | $6,800,000 | 6,128,297 | I |
| NELSEN ROBERT Director | 2022-10-24 | Conversion | +16,080 | 16,080 | I | ||
| Derivatives | |||||||
| NELSEN ROBERT Director | 2022-10-24 | Conversion · Series A Convertible Preferred Stock | −16,666,667 | 0 | I | ||
| NELSEN ROBERT Director | 2022-10-24 | Conversion · Series A Convertible Preferred Stock | −16,666,664 | 0 | I | ||
| NELSEN ROBERT Director | 2022-10-24 | Conversion · Series B Convertible Preferred Stock | −1,141,474 | 0 | I | ||
| NELSEN ROBERT Director | 2022-10-24 | Conversion · Series B Convertible Preferred Stock | −1,141,474 | 0 | I | ||
| NELSEN ROBERT Director | 2022-10-24 | Conversion · Series A Convertible Preferred Stock | −49,999 | 0 | I | ||
| Open-market purchases · 800,000 sh · avg $17.00 · $13,600,000 | |||||||
Loading xslF345X03/wf-form4_166682885724798.xml…